Same active ingredient — semaglutide — in a different delivery. The pill is once-daily by mouth; the injection is once-weekly under the skin. Both regulate appetite and blood sugar, and both produce comparable weight loss at their highest approved doses in clinical trials. The pill is the choice for anyone who’d rather skip the needle entirely.

One tablet in the morning, on an empty stomach, with a small sip of water — no more than 4 oz. Then wait at least 30 minutes before eating, drinking anything else, or taking other medications. Swallow the tablet whole. Your provider will walk you through the routine at your visit.

In the OASIS 4 clinical trial, adults with obesity or overweight with weight-related conditions lost an average of 16.6% of their body weight over 64 weeks on oral semaglutide 25 mg (among participants who adhered to treatment). Individual results vary based on adherence, diet, physical activity, and your own body — but for anyone who’s tried and stalled before, the numbers here are real.

Billed monthly — no long plans, no contracts. The 1.5 mg and 4 mg doses are $297/month. The 9 mg and 25 mg doses, and any titration plans, are $447/month. Your provider decides the right dose for you based on your intake and how you respond.

Wegovy® Pill is not appropriate for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), anyone who is pregnant, planning pregnancy, or breastfeeding, or anyone with a history of serious allergic reaction to semaglutide. You should discontinue at least 2 months before a planned pregnancy. Read the full Important Safety Information page before starting.